Shopping Cart 0
Cart Subtotal
USD 0

Shilpa Medicare Ltd (SHILPAMED) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Shilpa Medicare Ltd (SHILPAMED)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shilpa Medicare Ltd (Shilpa Medicare) focuses on the development, manufacture and commercialization of generic pharmaceutical products and active pharmaceutical ingredients (APIs). It offers medicines for the treatment of cancer, infectious diseases such as HIV, multiple sclerosis and immunological disorders among others. The company's cancer treatment products include anastrozole, bicalutamide, bortezomib, carboplatin and imatinibmesylate among others. Shilpa Medicare's API products include acebrophylline, valsartan, ambroxol HCl, buflomedil HCl, nifedipine and terfenadine, among others. It exports its drug products to the US, Canada, Australia, Japan, Germany, Switzerland and the Netherlands. The company also offers contract research and manufacturing services for APIs, formulations, new drug delivery systems (NDDS) and biotech products. Shilpa Medicare is headquartered in Raichur, Karnataka, India.

Shilpa Medicare Ltd Key Recent Developments

Jul 11,2018: Shilpa Medicare: Update on Establishment Inspection Report

Apr 23,2018: Shilpa Medicare Receives EU-GMP certification from AGES

Mar 17,2018: Shilpa Medicare Provides Update On USFDA Inspection At Formulation Unit At Jadcherla, Telangana

Mar 16,2018: Shilpa Medicare Provides Update On US FDA Inspection

Jan 22,2018: Shilpa Medicare Announces Completion of US FDA Inspection At API Facilities In Raichur, Karnataka

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Shilpa Medicare Ltd-Key Facts 5

Shilpa Medicare Ltd-Key Employees 6

Shilpa Medicare Ltd-Key Employee Biographies 7

Shilpa Medicare Ltd-Major Products and Services 8

Shilpa Medicare Ltd-History 10

Shilpa Medicare Ltd-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 14

Company Overview 14

Shilpa Medicare Ltd-Business Description 15

Shilpa Medicare Ltd-SWOT Analysis 16

SWOT Analysis-Overview 16

Shilpa Medicare Ltd-Strengths 16

Shilpa Medicare Ltd-Weaknesses 17

Shilpa Medicare Ltd-Opportunities 18

Shilpa Medicare Ltd-Threats 19

Shilpa Medicare Ltd-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Annual Ratios 21

Performance Chart 24

Financial Performance 24

Financial Ratios-Interim Ratios 25

Financial Ratios-Ratio Charts 26

Section 4-Company's Lifesciences Financial Deals and Alliances 27

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

Shilpa Medicare Ltd, Recent Deals Summary 29

Section 5-Company's Recent Developments 30

Jul 11, 2018: Shilpa Medicare: Update on Establishment Inspection Report 30

Apr 23, 2018: Shilpa Medicare Receives EU-GMP certification from AGES 31

Mar 17, 2018: Shilpa Medicare Provides Update On USFDA Inspection At Formulation Unit At Jadcherla, Telangana 32

Mar 16, 2018: Shilpa Medicare Provides Update On US FDA Inspection 33

Dec 05, 2017: Shilpa Medicare receives 483 observations from US FDA for SEZ Formulation Facilities 34

Oct 24, 2017: Shilpa Medicare: Resignation of Chief Financial Officer (CFO) 35

Oct 07, 2017: Shilpa Medicare: Intimation U/R 3O of the SEBI(LODR) Regulations- Reg. Ref: Stock Code: NSE: SHILPAMED/BSE-53O549 36

Jul 31, 2017: Shilpa Medicare Provides Update On US FDA Inspection At manufacturing facility located at Jadcherla, Telangana 37

Apr 12, 2017: Shilpa Medicare Provides Update On US FDA Inspection At Manufacturing Facilities Located At Raichur 38

Section 6-Appendix 39

Methodology 39

Ratio Definitions 39

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

Shilpa Medicare Ltd, Performance Chart (2014-2018) 24

Shilpa Medicare Ltd, Ratio Charts 26

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28


List Of Table

List of Tables

Shilpa Medicare Ltd, Key Facts 5

Shilpa Medicare Ltd, Key Employees 6

Shilpa Medicare Ltd, Key Employee Biographies 7

Shilpa Medicare Ltd, Major Products and Services 8

Shilpa Medicare Ltd, History 10

Shilpa Medicare Ltd, Other Locations 12

Shilpa Medicare Ltd, Subsidiaries 12

Shilpa Medicare Ltd, Key Competitors 20

Shilpa Medicare Ltd, Annual Ratios 21

Shilpa Medicare Ltd, Annual Ratios (Cont...1) 22

Shilpa Medicare Ltd, Annual Ratios (Cont...2) 23

Shilpa Medicare Ltd, Interim Ratios 25

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

Shilpa Medicare Ltd, Recent Deals Summary 29

Currency Codes 39

Capital Market Ratios 39

Equity Ratios 40

Profitability Ratios 40

Cost Ratios 41

Liquidity Ratios 41

Leverage Ratios 42

Efficiency Ratios 42

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Shilpa Medicare Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Natco Pharma Ltd

MSN Laboratories Pvt Ltd

Lupin Ltd

Glenmark Pharmaceuticals Ltd